Discontinued — last reported Q3 '25
West Pharmaceutical Services Finance Lease Liability - Undiscounted Excess Amount decreased by 20.0% to $400.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from $200.00K to $400.00K. This is a positive signal — lower values indicate better performance for this metric.
A higher amount indicates a larger interest component or longer lease terms, reflecting the total cash obligation beyond the current accounting valuation.
This metric represents the difference between the total undiscounted future payments for finance leases and the present...
Reported by companies with significant finance lease arrangements for capital equipment.
finance_lease_liability_undiscounted_excess| Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $300.00K | $300.00K | $200.00K | $500.00K | $500.00K | $400.00K |
| QoQ Change | — | +0.0% | -33.3% | +150.0% | +0.0% | -20.0% |
| YoY Change | — | — | — | +66.7% | +66.7% | +100.0% |